Screener
Aclaris Therapeutics ACRS Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Total costs and expenses | 25,867 | 20,185 | 50,055 | 39,724 |
| Loss from operations | (24,238) | (18,408) | (46,430) | (36,492) |
| Other income: | ||||
| Interest income | 1,761 | 2,018 | 3,275 | 4,184 |
| Non-cash royalty income | 972 | 961 | 1,826 | 1,794 |
| Total other income | 2,733 | 2,979 | 5,101 | 5,978 |
| Net loss | $(21,505) | $(15,429) | $(41,329) | $(30,514) |
| Net loss per share, basic and diluted | $(0.15) | $(0.13) | $(0.30) | $(0.25) |
Item 1. Financial Statements
FAQ
- What is Aclaris Therapeutics's interest income?
- Aclaris Therapeutics (ACRS) reported interest income of $1.76M in Q2 2026.
- How has Aclaris Therapeutics's interest income changed year-over-year?
- Aclaris Therapeutics's interest income decreased by 12.7% year-over-year, from $2.02M to $1.76M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Aclaris Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude